Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
17.49
-0.46 (-2.56%)
At close: Jul 24, 2025, 4:00 PM
16.98
-0.51 (-2.92%)
After-hours: Jul 24, 2025, 5:56 PM EDT

Viridian Therapeutics Stock Forecast

Stock Price Forecast

The 11 analysts that cover Viridian Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $38.5, which forecasts a 120.13% increase in the stock price over the next year. The lowest target is $27 and the highest is $61.

Price Target: $38.5 (+120.13%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$27$38.5$38$61
Change+54.37%+120.13%+117.27%+248.77%
* Price targets were last updated on May 20, 2025.

Analyst Ratings

The average analyst rating for Viridian Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy555555
Buy444665
Hold333111
Sell000000
Strong Sell000000
Total121212121211

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Needham
Needham
Strong Buy
Reiterates
$36
Strong BuyReiterates$36+105.83%May 20, 2025
RBC Capital
RBC Capital
Buy
Maintains
$46$45
BuyMaintains$46$45+157.29%May 7, 2025
Goldman Sachs
Goldman Sachs
Strong Buy
Maintains
$31$27
Strong BuyMaintains$31$27+54.37%May 7, 2025
JMP Securities
JMP Securities
Buy
Maintains
$42$38
BuyMaintains$42$38+117.27%May 7, 2025
Needham
Needham
Strong Buy
Maintains
$38$36
Strong BuyMaintains$38$36+105.83%May 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
202.33K
from 302.00K
Decreased by -33.00%
Revenue Next Year
34.81M
from 202.33K
Increased by 17,102.33%
EPS This Year
-4.03
from -3.07
EPS Next Year
-3.88
from -4.03
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
1.05M2.96M1.77M314.00K302.00K202.33K34.81M247.28M
Revenue Growth
-76.46%182.19%-40.20%-82.28%-3.82%-33.00%17,102.33%610.47%
EPS
-31.13-6.66-2.71-3.91-3.07-4.03-3.88-2.10
EPS Growth
--------
Forward PE
--------
No. Analysts
-----171712
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High863,10096.9M428.4M
Avg202,32734.8M247.3M
Lown/an/a102.9M

Revenue Growth

Revenue Growth20252026202720282029
High
185.8%
47,800.1%
1,130.9%
Avg
-33.0%
17,102.3%
610.5%
Low--
195.6%

EPS Forecast

EPS20252026202720282029
High-3.41-2.99-1.07
Avg-4.03-3.88-2.10
Low-4.67-5.15-2.98

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.